{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:10:12Z","timestamp":1778947812172,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.114041","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:47:53Z","timestamp":1752713273000},"page":"114041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Repurposing mesalamine for acute kidney injury through supramolecular assembly"],"prefix":"10.1016","volume":"385","author":[{"given":"Byeongmin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hochung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Sook","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwoong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Won","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Kyung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangmeyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoosoo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Kyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114041_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: a global perspective of a silent killer","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ki.2014.328","article-title":"The definition of acute kidney injury and its use in practice","volume":"87","author":"Thomas","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.kint.2020.06.032","article-title":"A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death","volume":"99","author":"Ikizler","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.114041_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41581-019-0247-z","article-title":"Long-term outcomes of acute kidney injury and strategies for improved care","volume":"16","author":"James","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0030","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2215\/CJN.01540213","article-title":"Use of peritoneal dialysis in AKI: a systematic review","volume":"8","author":"Chionh","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114041_bb0040","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.drudis.2022.05.026","article-title":"Drug repurposing: an effective strategy to accelerate contemporary drug discovery","volume":"27","author":"Zhan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114041_bb0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor \u03baB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114041_bb0050","first-page":"437","article-title":"5-aminosalicylic acid inhibits iNOS transcription in human intestinal epithelial cells","volume":"4","author":"Kennedy","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114041_bb0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004836-200102000-00019","article-title":"Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine","volume":"32","author":"Margetts","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2019.09.002","article-title":"The association of mesalamine with kidney disease","volume":"27","author":"Adiga","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.jconrel.2025.114041_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.addr.2004.08.008","article-title":"Mesalamine delivery systems: do they really make much difference?","volume":"57","author":"Qureshi","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114041_bb0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ibd.20125","article-title":"Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis","volume":"13","author":"Fukunaga","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"2019","key":"10.1016\/j.jconrel.2025.114041_bb0075","first-page":"S1161","article-title":"2083 Mesalamine-induced myocarditis","volume":"114","author":"Putnam","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5223\/pghn.2015.18.4.286","article-title":"Mesalizine-induced acute pancreatitis and interstitial pneumonitis in a patient with ulcerative colitis","volume":"18","author":"Chung","year":"2015","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.jconrel.2025.114041_bb0085","first-page":"5766","article-title":"Engineering \u03c0-conjugation of phenylalanine derivatives for controllable chiral folding and self-assemblies","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114041_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414146","article-title":"Self-assembled peptide-derived proteolysis-targeting chimera (PROTAC) Nanoparticles for tumor-targeted and durable PD-L1 degradation in Cancer immunotherapy","volume":"64","author":"Moon","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.114041_bb0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jconrel.2018.11.032","article-title":"Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy","volume":"294","author":"Shim","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114041_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120347","article-title":"Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy","volume":"261","author":"Shim","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114041_bb0105","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.7150\/thno.69119","article-title":"Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death","volume":"12","author":"Moon","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114041_bb0110","doi-asserted-by":"crossref","first-page":"14698","DOI":"10.1002\/anie.201608504","article-title":"Cathepsin B-specific metabolic precursor for in vivo tumor-specific fluorescence imaging","volume":"55","author":"Shim","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.114041_bb0115","article-title":"Light-triggered PROTAC nanoassemblies for photodynamic IDO proteolysis in cancer immunotherapy","volume":"36","author":"Choi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114041_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121806","article-title":"Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy","volume":"289","author":"Shim","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114041_bb0125","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1021\/acsnano.1c03416","article-title":"Visible-light-triggered prodrug nanoparticles combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy","volume":"15","author":"Choi","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114041_bb0130","doi-asserted-by":"crossref","first-page":"16297","DOI":"10.1021\/acsnano.4c05544","article-title":"Mucoadhesive Mesalamine prodrug Nanoassemblies to target intestinal macrophages for the treatment of inflammatory bowel disease","volume":"18","author":"Park","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114041_bb0135","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jconrel.2020.10.065","article-title":"Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance","volume":"330","author":"Kim","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114041_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120791","article-title":"Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity","volume":"272","author":"Yang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114041_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","article-title":"Oxidative stress and the role of redox signalling in chronic kidney disease","volume":"20","author":"Kishi","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0150","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.114041_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114041_bb0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114041_bb0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1440-1746.2003.03056.x","article-title":"Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection","volume":"18","author":"Teoh","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0170","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2015070740","article-title":"Cellular and molecular mechanisms of AKI","volume":"27","author":"Agarwal","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0175","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0185","doi-asserted-by":"crossref","first-page":"F1501","DOI":"10.1152\/ajprenal.00195.2018","article-title":"Immune cells and inflammation in AKI to CKD progression","volume":"315","author":"Sato","year":"2018","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg3076","article-title":"Signatures for drug repositioning","volume":"12","author":"Harrison","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2025.114041_bb0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","article-title":"A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data","volume":"3","author":"Liu","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.jconrel.2025.114041_bb0200","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/nbt.2758","article-title":"Rational drug repositioning by medical genetics","volume":"31","author":"Wang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","article-title":"Drug repurposing in kidney disease","volume":"94","author":"Panchapakesan","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.gtc.2020.07.002","article-title":"Mesalamine in the initial therapy of ulcerative colitis","volume":"49","author":"Chibbar","year":"2020","journal-title":"Gastroenterol. Clin."},{"key":"10.1016\/j.jconrel.2025.114041_bb0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.1.5793.152","article-title":"Nephrotoxic lesions from 5-aminosalicylic acid","volume":"1","author":"Calder","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jconrel.2025.114041_bb0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/0253-7613.178840","article-title":"The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats","volume":"48","author":"Banaei","year":"2016","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114041_bb0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Gastroenterology, ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114041_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114041_bb0235","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114041_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114357","article-title":"Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment","volume":"187","author":"Tarannum","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114041_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114177","article-title":"Tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy: preclinical evidence for safe and effective drug delivery","volume":"183","author":"Kyu Shim","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114041_bb0250","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114041_bb0255","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.kint.2023.03.025","article-title":"Acute kidney injury and distant organ dysfunction\u2013network system analysis","volume":"103","author":"Matsuura","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2025.114041_bb0260","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3892\/mmr.2014.2089","article-title":"Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice","volume":"9","author":"Kang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2025.114041_bb0265","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/thno.101358","article-title":"Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure","volume":"15","author":"Park","year":"2025","journal-title":"Theranostics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:20:50Z","timestamp":1778944850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"alternative-id":["S0168365925006625"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing mesalamine for acute kidney injury through supramolecular assembly","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114041"}}